Wei Lin - 01 Mar 2025 Form 4 Insider Report for Revolution Medicines, Inc. (RVMD)

Role: Chief Medical Officer
Signature: /s/ Jack Anders, as Attorney-in-fact for Wei Lin
Issuer symbol: RVMD
Transactions as of: 01 Mar 2025
Transactions value $: $0
Form type: 4
Filing time: 04 Mar 2025, 19:01:36 UTC
Previous filing: 20 Jun 2024
Next filing: 15 May 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RVMD	Common Stock	Award	$0	-20.8K	-18.5%	$0.00	91.7K	01 Mar 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RVMD	Stock Option (Right to Buy)	Award	$0	+72.8K		$0.00	72.8K	01 Mar 2025	Common Stock	72.8K	$40.74	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 70,750 restricted stock units.
F2	One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2025 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.

Content

Includes 70,750 restricted stock units.

One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2025 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.